C07K 14/61
Growth hormone [gh], i.e. somatotropin
Official title: Growth hormone [GH], i.e. somatotropin
C07K14/61 (Growth hormone [gh], i.e. somatotropin) appears on 849 US grants and 798 published applications in this corpus.
Search patents in C07K- Granted patents
- 849
- Published applications
- 798
- Assignees
- 394
- Inventors
- 1,576
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 6 | 0 |
| 1987 | 18 | 0 |
| 1988 | 11 | 0 |
| 1989 | 15 | 0 |
| 1990 | 12 | 0 |
| 1991 | 19 | 0 |
| 1992 | 25 | 0 |
| 1993 | 18 | 0 |
| 1994 | 12 | 0 |
| 1995 | 12 | 0 |
| 1996 | 23 | 0 |
| 1997 | 38 | 0 |
| 1998 | 48 | 0 |
| 1999 | 35 | 0 |
| 2000 | 25 | 0 |
| 2001 | 30 | 5 |
| 2002 | 23 | 19 |
| 2003 | 20 | 41 |
| 2004 | 21 | 44 |
| 2005 | 14 | 35 |
| 2006 | 15 | 43 |
| 2007 | 17 | 30 |
| 2008 | 15 | 79 |
| 2009 | 25 | 41 |
| 2010 | 28 | 32 |
| 2011 | 32 | 46 |
| 2012 | 31 | 30 |
| 2013 | 18 | 25 |
| 2014 | 29 | 56 |
| 2015 | 35 | 34 |
| 2016 | 20 | 31 |
| 2017 | 23 | 21 |
| 2018 | 25 | 29 |
| 2019 | 11 | 21 |
| 2020 | 14 | 29 |
| 2021 | 16 | 21 |
| 2022 | 10 | 18 |
| 2023 | 15 | 30 |
| 2024 | 8 | 13 |
| 2025 | 12 | 19 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- AAV5-based vaccine against SARS-CoV-215 Sep 2026US 12,734,235 B2
- Inter-application workflow performance analytics18 Aug 2026US 12,711,443 B2Box, Inc.
- Fusion polypeptide comprising polypeptide region that can be O-glycosylated28 Apr 2026US 12,612,469 B2LG Chem.Ltd.
- Pharmaceuticals and dosing means for human aging reversal14 Apr 2026US 12,599,651 B2Intervene Immune Inc.
- Gene therapies for lysosomal disorders10 Mar 2026US 12,570,963 B2Prevail Therapeutics, Inc.
- Ghr-binding peptide and composition comprising same23 Jul 2026US 2026/0209276 A1PeptiDream Inc.
- Conjugate of recombinant human serum albumin and recombinant human growth hormone, and preparation method therefor9 Jul 2026US 2026/0193308 A1Wuhan Healthgen Biotechnology Corp
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Gene therapies for lysosomal disorders18 Jun 2026US 2026/0167941 A1Prevail Therapeutics, Inc.
- Enhanced peptide constructs for albumin binding8 Jan 2026US 2026/0008820 A1
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- In vivo introduction and expression of foreign genetic material in epithelial cells586US 4,980,286 AWhitehead Institute for Biomedical Research · 1990
- Monovalent phage display562US 5,821,047 AGenentech, Inc. · 1998